Deborah Ann Law

Title: Innovations and Contributions of Deborah Ann Law

Introduction

Deborah Ann Law is a notable inventor based in San Francisco, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of transgenic mammals and integrin-mediated signaling.

Latest Patents

Deborah Ann Law holds 2 patents. Her latest patents include "Transgenic mammals expressing mutant GP IIIa," which relates to mammals that have been genetically modified to study the effects of altered GP IIIa genes on platelet function. This invention provides a critical tool for assessing the importance of phosphorylation reactions in biological processes. Another patent, "Modulation of integrin-mediated signal transduction," discloses the necessity of phosphorylation of cytoplasmic tyrosine residues in integrins for signal protein association. This invention outlines methods for identifying signaling partners and agents that can modulate integrin-mediated signaling.

Career Highlights

Throughout her career, Deborah has worked with prominent companies such as Millennium Pharmaceuticals Limited and Cor Therapeutics, Inc. Her work has significantly advanced the understanding of integrin functions and their implications in various biological processes.

Collaborations

Deborah has collaborated with notable individuals in her field, including David R. Phillips and Lisa Nannizzi Alaimo. These collaborations have further enriched her research and contributions to biotechnology.

Conclusion

Deborah Ann Law's innovative work in the field of biotechnology has led to important advancements in understanding genetic modifications and their applications. Her patents and collaborations reflect her commitment to scientific progress and innovation.